drugset / Trial / NCT02750332

Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)

NCT02750332

Phase 1 Completed 20 enrolled Cycle Pharmaceuticals Ltd. Parexel · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the bioavailability of the Test Product, Nitisinone 10 mg Tablet, under fasting and fed conditions (food-effect).

Timeline

Start
2015-11
Primary completion
2015-12
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitisinone Small molecule 10 mg Oral

Indications